The proof is in the numbers.
Cerenetex Clinical Data
A proof-of-concept study was launched on individuals with migraines to showcase the potential of using acoustics for neuropathology detection.
- Placebo Control: 20 Patients
- Asymptomatic: 30 Patients
- Active: 10 Patients
- RX Therapy: 6 Patients
